Page 1

LeMaitre Q2 2021 Financial Results July 29 , 2021 BURLINGTON , Mass . , July 29 , 2021 ( GLOBE NEWSWIRE ) -- LeMaitre ( Nasdaq : LMAT ) , a provider of vascular devices , implants and services , today reported Q2 2021 results , announced an $ 0.11 / share quarterly dividend and provided guidance . Q2 2021 Financial Results • Sales of $ 40.7mm , + 64 % ( + 35 % organic ) vs. Q2 2020 • Op . income of $ 11.1mm , + 128 % • Op . margin of 27 % • Net income of $ 8.3mm , + 137 % • Earnings of $ 0.40 per diluted share , + 131 % • EBITDA of $ 13.3mm , + 108 % Q2 2021 sales were driven by Artegraft ( $ 6.7mm ) , valvulotomes , carotid shunts , patches and allografts . By geography , the Americas was up 83 % , Europe / Middle East / Africa + 36 % and Asia / Pac + 30 % . The gross margin decline to 65.8 % ( vs. 68.5 % in Q2 2020 ) was driven by changes in product mix , manufacturing inefficiencies from 2020 personnel reductions , and inventory write - downs . Q2 2021 op . income increased 128 % to $ 11.1mm in Q2 2021 , more than 1/3 of which was contributed by Artegraft . Op . income was also up due to restrained headcount growth . On July 16 2021 , the Company completed a $ 54.5mm follow - on public stock offering . $ 23.0mm of the net proceeds were used to repay long - term debt , with the remainder to be used for general corporate purposes . George LeMaitre , Chairman and CEO , said , " The addition of Artegraft and restrained op . expenses increased profits 128 % . " Business Outlook Item Sales Gross Margin Op . Income EPS Q3 2021 Guidance $ 38.3mm $ 40.3mm ( Midpoint : $ 39.3 , + 8 % ) 66.6 % $ 9.3mm $ 10.6mm ( Midpoint : $ 10.0mm , -1 % ) $ 0.30 - $ 0.35 ( Midpoint : $ 0.33 , -11 % ) Q4 2021 Guidance $ 39.3mm $ 41.3mm ( Midpoint : $ 40.3 , + 7 % ) 67.5 % $ 9.3mm $ 10.7mm ( Midpoint : $ 10.0mm , + 5 % ) $ 0.33 - $ 0.38 ( Midpoint : $ 0.35 , + 4 % ) FY 2021 Guidance $ 154.1mm $ 158.1mm ( Midpoint : $ 156.1 , + 21 % ) 66.6 % $ 37.7mm - $ 40.4mm ( Midpoint : $ 39.0mm , + 36 % ) $ 1.30 - $ 1.40 ( Midpoint : $ 1.35 , + 30 % ) Quarterly Dividend On July 22 , 2021 , the Company's Board of Directors approved a quarterly dividend of $ 0.11 / share of common stock . The dividend will be paid on September 9 , 2021 to shareholders of record on August 26 , 2021 . Conference Call Reminder Management will conduct a conference call at 5:00 pm ET today . The conference call will be broadcast live over the Internet . Individuals interested in listening to the webcast can log on to the Company's website at www.lemaitre.com/investor . The conference call may also be accessed by dialing 844-239-5284 ( +1 512-961-6497 for international callers ) , using passcode 1899078. For individuals unable to join the live conference call , a replay will be available on the Company's website . A reconciliation of GAAP to non - GAAP results is included in the tables attached to this release . About LeMaitre LeMaitre is a provider of devices , implants and services for the treatment of peripheral vascular disease , a condition that affects more than 200 million people worldwide . The Company develops , manufactures and markets disposable and implantable vascular devices to address the needs of its core customer , the vascular surgeon . LeMaitre is a registered trademark of LeMaitre Vascular , Inc. This press release may include other trademarks and trade names of the Company . For more information about the Company , please visit http://www.lemaitre.com . Use of Non - GAAP Financial Measures LeMaitre Vascular management believes that in order to better understand the Company's short - term and long - term financial trends , investors may wish to consider certain non - GAAP financial measures as a supplement to financial performance measures prepared in accordance with GAAP . Non - GAAP financial measures are not based on a comprehensive set of accounting rules or principles and do not have standardized meanings . These non - GAAP measures result from facts and circumstances that may vary in frequency and / or impact on continuing operations . Non - GAAP